Titlebook: Ovarian Cancer; State of the Art and George Coukos,Andrew Berchuck,Robert Ozols Conference proceedings 2008 The Editor(s) (if applicable) a

敵手

Epigenetic Markers of Ovarian Cancer; however, although the majority of patients are initially responsive to chemotherapy, most of them eventually develop drug-resistant disease, that is essentially incurable. A better understanding of the molecular pathogenesis underlying ovarian cancer is the key to identifying markers for early detection and novel therapeutics.

Palpable

小隔間

乳白光

Individualized Molecular Medicine: Linking Functional Proteomics to Select Therapeutics Targeting thll need to become individualized. Specifically targeted drugs continue to receive FDA approval and guide treatment selection on the basis of the underlying dysfunctional genetic, transcriptional, or protein regulation driving their tumor progression.

TERRA

tenosynovitis

榮幸

George Coukos,Andrew Berchuck,Robert OzolsMeeting will function as a think tank where clinicians, translational and basic scientists, and parties from the biotechnology and pharmaceutical industry will get together to review recent advances i

ABOUT

AV-node

https://doi.org/10.1007/978-0-387-68969-2B7 family members; BRCA; Carcinom; Epigenetic markers; Ovarian Cancer; Ovulatory factor; Pathogenesis; Regu

elastic

Mandi M. Murph,Debra L. Smith,Bryan Hennessy,Yiling Lu,Corwin Joy,Kevin R. Coombes,Gordon B. Millsormation toward understanding the nature and mechanism of the underlying disorders..The book represents a unique mixture of textbook and atlas, always combining concise statements in English, German, and Spanish on one page with didactically conceived explanatory illustrations on the facing page. ..978-3-642-44085-4978-3-540-30061-8